SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Pharmacy Benefit Managers
6 references·1 citing·33 second hop
Pharmacy Benefit Managers (2023)Pharmacy Benefit ManagersUS Health Care Spending by Payer and Health Condition, 1996-2016 (2020)US Health Care Spending by Pa…Refocusing Medication Prior Authorization on Its Intended Purpose (2020)Refocusing Medication Prior A…The Impact Of Specialty Pharmaceuticals As Drivers Of Health Care Costs (2014)The Impact Of Specialty Pharm…Agency Theory and Bounded Self-Interest (2014)Agency Theory and Bounded Sel…U.S. Government Accountability Office (2013)U.S. Government Accountabilit…Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions (1997)Pharmacy benefit management, …More US Pharmacies Closed Than Opened In 2018–21; Independent Pharmacies, Those In Black, Latinx Communities Most At Risk (2024)More US Pharmacies Closed Tha…A theory of justice original edition (1971)Theory of the firm: Managerial behavior, agency costs and ownership structure (1976)Agency Theory: An Assessment and Review (1989)Stakeholder Theory and the Resource-Based View of the Firm (2021)The Relationship between Stakeholder Theory and Corporate Social Responsibility: Differences, Similarities, and Implications for Social Issues in Management (2021)Stakeholder Engagement: Past, Present, and Future (2022)The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)National trends in prescription drug expenditures and projections for 2014 (2014)The 340B Drug Discount Program: Hospitals Generate Profits By Expanding To Reach More Affluent Communities (2014)Mind the Gap: Why Closing the Doughnut Hole Is Insufficient for Increasing Medicare Beneficiary Access to Oral Chemotherapy (2015)Why Are Biosimilars Not Living up to Their Promise in the US? (2019)The association between cost sharing, prior authorization, and specialty drug utilization: A systematic review (2023)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Returns to R&D on new drug introductions in the 1980s (1994)The Managed Health Care Handbook (1998)Effective patent life in pharmaceuticals (2000)Economic Evaluations of Healthcare Programmes and Decision Making (2005)Providing Prescription Drug Coverage to the Elderly: America's Experiment with Medicare Part D (2008)The Medicare Payment Advisory Commission. (1998)Health Care Spending in the United States and Other High-Income Countries (2018)Administrative Burden and Costs of Prior Authorizations in a Dermatology Department (2020)Out-Of-Pocket Medical Spending For Care Of Chronic Conditions (2001)Cancer treatment cost in the United States (2010)US Spending on Personal Health Care and Public Health, 1996-2013 (2016)Spending on Cardiovascular Disease and Cardiovascular Risk Factors in the United States: 1996 to 2016 (2021)Trends in Differences in Health Status and Health Care Access and Affordability by Race and Ethnicity in the United States, 1999-2018 (2021)Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050 (2023)‘Pharmacy Deserts’ Are Prevalent In Chicago’s Predominantly Minority Communities, Raising Medication Access Concerns (2014)Fewer Pharmacies In Black And Hispanic/Latino Neighborhoods Compared With White Or Diverse Neighborhoods, 2007–15 (2021)The Problem Of The Color Line: Spatial Access To Hospital Services For Minoritized Racial And Ethnic Groups (2022)Detention of Immigrant Children (2017)Protect, Serve, and Deport: The Rise of Policing as Immigration Enforcement (2017)Costs of Drug Development and Research and Development Intensity in the US, 2000-2018 (2024)
this work references cited by second hop

References

  • 2020US Health Care Spending by Payer and Health Condition, 1996-20161,370 cited
  • 2013U.S. Government Accountability Office997 cited
  • 2014Agency Theory and Bounded Self-Interest538 cited
  • 1997Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions94 cited
  • 2020Refocusing Medication Prior Authorization on Its Intended Purpose65 cited
  • 2014The Impact Of Specialty Pharmaceuticals As Drivers Of Health Care Costs62 cited

Cited by

  • 2024More US Pharmacies Closed Than Opened In 2018–21; Independent Pharmacies, Those In Black, Latinx Communities Most At Risk50 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work